On Tuesday, Nymox Pharmaceutical Corporation (NASDAQ:NYMX)’s shares declined -13.58% to $1.40.
Nymox Pharmaceutical Corporation (NYMX) declared long-term clinical trial results from the Company’s NX-1207 Phase 2 prostate cancer study NX03-0040. The new results demonstrate statistically noteworthy (p=.0067) better outcomes at up to 2.8 years for NX-1207 treated patients contrast to controls. Trial participants comprised of 146 patients with low grade localized prostate cancer at 44 U.S. investigational sites.
Nymox Pharmaceutical Corporation, a biopharmaceutical company, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to tobacco products, in addition to AlzheimAlert, a proprietary urine assay that aid physicians in the diagnosis of Alzheimer’s disease.
Paragon Offshore PLC (NYSE:PGN)’s shares dropped -12.87% to $1.76.
Paragon Offshore PLC (PGN) declared that it plans to report financial results for the first quarter 2015 on Wednesday, May 13, 2015, after the close of trading on the New York Stock Exchange. Copies of Paragon’s earnings release will be accessible on its website at www.paragonoffshore.com.
Paragon Offshore plc, together with its auxiliaries, provides offshore drilling rigs. The company is involved in contracting its rigs, related equipment, and work crews to conduct oil and gas drilling and workover operations for its exploration and production customers on a day rate basis.
At the end of Tuesday’s trade, Sanmina Corp (NASDAQ:SANM)‘s shares dipped -11.43% to $20.69.
Sanmina Corp (SANM) stated financial results for the second fiscal quarter ended March 28, 2015.
Second Quarter Fiscal 2015 Summary
- Revenue of $1.53 billion
- GAAP operating margin of 3.3 percent
- GAAP diluted earnings per share of $0.17
- Non-GAAP(1)operating margin of 3.7 percent
- Non-GAAP(1)diluted earnings per share of $0.50
Revenue for the second quarter was $1.53 billion, contrast to $1.67 billion in the preceding quarter and $1.48 billion for the same period of fiscal 2014.
Sanmina Corporation provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services worldwide. It offers product design and engineering services, counting initial development, detailed design, prototyping, validation, preproduction, and manufacturing design; manufacturing of components, subassemblies, and complete systems; final system assembly and test; direct order fulfillment and logistics, and supply chain administration services; and after-market product service and support.
Flotek Industries Inc (NYSE:FTK), ended its Tuesday’s trading session with -10.43% loss, and closed at $15.46.
Flotek Industries Inc (FTK) this morning declared the Company’s plan for its first quarter earnings release and conference call. The Company also declared its forthcoming presentation at the Independent Petroleum Association of America New York Oil and Gas Investment Symposium.
Flotek will host a conference call on Thursday, April 23, 2015, at 7:00 am CDT (8:00am EDT) to talk about its financial and operating results for the three-months ended March 31, 2015.
Flotek Industries, Inc. develops and supplies oilfield products, services, and equipment to the oil, gas, and mining industries in the United States and internationally. Its Energy Chemical Technologies segment designs, develops, manufactures, packages, and markets specialty chemicals used in oil and gas well drilling, cementing, completion, stimulation, and production.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
